Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study
Anum Shaikh; Gabriel Pedra; Leonardo Ruiz-Casas; Bethany Franks; Harpal Dhillon; João Diogo da Rocha Fernandes; Kamal Kant Mangla; Margarida Augusto; Manuel Romero-Gómez; Jörn M. Schattenberg;
Gastroenterol Hepatol. 2024;47:463-72
Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: Results of a Delphi study
Rocío Aller; José Luis Calleja; Javier Crespo; Manuel Romero-Gómez; Juan Turnes; Omar J. Benmarzouk-Hidalgo; Rafael Subirán; Alicia Gil;
Gastroenterol Hepatol. 2024;47:337-46
Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-¿B signaling
Yingwei Zhu; Hong Tang; Han Zhao; Jian Lu; Kai Lin; Jingbin Ni; Bo Zhao; Gaojue Wu; Chunxiao Tan;
Gastroenterol Hepatol. 2024;47:366-76